Institute of Hypertension, Zhongshan School of Medicine, Sun Yat-sen University, Guangzhou, China.
School of Basic Medical Sciences, Guangzhou Medical University, Guangzhou, China; and.
FASEB J. 2019 Jan;33(1):469-483. doi: 10.1096/fj.201800436R. Epub 2018 Jul 23.
Increasing evidence supports the important role of HS in renal physiology and the pathogenesis of kidney injury. Whether HS regulates water metabolism in the kidney and the potential mechanism are still unknown. The present study was conducted to determine the role of HS in urine concentration. Inhibition of both cystathionine-γ-lyase (CSE) and cystathionine-β-synthase (CBS), 2 major enzymes for endogenous HS production, with propargylglycine (PPG) and amino-oxyacetate (AOAA), respectively, caused increased urine output and reduced urine osmolality in mice that was associated with decreased expression of aquaporin (AQP)-2 in the renal inner medulla. Mice treated with both PPG and AOAA developed a urine concentration defect in response to dehydration that was accompanied by reduced AQP-2 protein expression. Inhibition of CSE alone was associated with a mild decrease in AQP-2 protein level in the renal medulla of heterozygous CBS mice. GYY4137, a slow HS donor, markedly improved urine concentration and prevented the down-regulation of renal AQP-2 protein expression in mice with lithium-induced nephrogenic diabetes insipidus (NDI). GYY4137 significantly increased cAMP levels in cell lysates prepared from inner medullary collecting duct (IMCD) suspensions. AQP-2 protein expression was also upregulated, but was significantly inhibited by the adenyl cyclase inhibitor MDL12330A or the PKA inhibitor H89, but not the vasopressin 2 receptor (VR) antagonist tolvaptan. Inhibition of endogenous HS production impaired urine concentration in mice, whereas an exogenous HS donor improved urine concentration in lithium-induced NDI by increasing AQP-2 expression in the collecting duct principal cells. HS upregulated AQP-2 protein expression, probably via the cAMP-PKA pathway.-Luo, R., Hu, S., Liu, Q., Han, M., Wang, F., Qiu, M., Li, S., Li, X., Yang, T., Fu, X., Wang, W., Li, C. Hydrogen sulfide upregulates renal AQP-2 protein expression and promotes urine concentration.
越来越多的证据支持 HS 在肾脏生理学和肾脏损伤发病机制中的重要作用。HS 是否调节肾脏的水代谢以及潜在的机制尚不清楚。本研究旨在确定 HS 在尿液浓缩中的作用。分别用炔丙基甘氨酸(PPG)和氨基氧乙酸(AOAA)抑制胱硫醚-γ-裂解酶(CSE)和胱硫醚-β-合酶(CBS)这两种内源性 HS 产生的主要酶,可导致小鼠尿量增加,尿渗透压降低,与肾脏髓质中水通道蛋白(AQP)-2的表达降低有关。用 PPG 和 AOAA 处理的小鼠在脱水时出现尿液浓缩缺陷,伴有 AQP-2 蛋白表达减少。单独抑制 CSE 会导致杂合型 CBS 小鼠肾髓质中 AQP-2 蛋白水平轻度降低。HS 缓慢供体 GYY4137 可显著改善尿液浓缩,并防止锂诱导的肾性尿崩症(NDI)小鼠肾 AQP-2 蛋白表达下调。GYY4137 显著增加了从髓质集合管(IMCD)悬液中制备的细胞裂解物中的 cAMP 水平。AQP-2 蛋白表达也上调,但被腺苷酸环化酶抑制剂 MDL12330A 或蛋白激酶 A 抑制剂 H89 显著抑制,但不是血管加压素 2 受体(VR)拮抗剂托伐普坦。抑制内源性 HS 产生可损害小鼠尿液浓缩,而外源性 HS 供体通过增加集合管主细胞中的 AQP-2 表达,改善锂诱导的 NDI 中的尿液浓缩。HS 上调 AQP-2 蛋白表达,可能通过 cAMP-PKA 途径。-罗,R.,胡,S.,刘,Q.,韩,M.,王,F.,邱,M.,李,S.,李,X.,杨,T.,傅,X.,王,W.,李,C. 硫化氢上调肾脏 AQP-2 蛋白表达并促进尿液浓缩。